Journey Medical Corp (DERM)
3.57
+0.13
(+3.78%)
USD |
NASDAQ |
May 08, 16:00
3.58
+0.01
(+0.28%)
After-Hours: 20:00
Journey Medical Enterprise Value: 58.49M for May 8, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 08, 2024 | 58.49M |
| May 07, 2024 | 55.89M |
| May 06, 2024 | 58.09M |
| May 03, 2024 | 60.88M |
| May 02, 2024 | 59.68M |
| May 01, 2024 | 57.29M |
| April 30, 2024 | 60.88M |
| April 29, 2024 | 53.69M |
| April 26, 2024 | 55.09M |
| April 25, 2024 | 56.95M |
| April 24, 2024 | 54.95M |
| April 23, 2024 | 57.74M |
| April 22, 2024 | 57.74M |
| April 19, 2024 | 56.55M |
| April 18, 2024 | 58.54M |
| April 17, 2024 | 64.12M |
| April 16, 2024 | 62.93M |
| April 15, 2024 | 67.31M |
| April 12, 2024 | 75.28M |
| April 11, 2024 | 73.09M |
| April 10, 2024 | 74.49M |
| April 09, 2024 | 66.91M |
| April 08, 2024 | 69.10M |
| April 05, 2024 | 60.53M |
| April 04, 2024 | 74.09M |
| Date | Value |
|---|---|
| April 03, 2024 | 55.35M |
| April 02, 2024 | 54.95M |
| April 01, 2024 | 53.16M |
| March 28, 2024 | 60.53M |
| March 27, 2024 | 62.35M |
| March 26, 2024 | 58.49M |
| March 25, 2024 | 43.61M |
| March 22, 2024 | 50.95M |
| March 21, 2024 | 61.00M |
| March 20, 2024 | 61.39M |
| March 19, 2024 | 60.42M |
| March 18, 2024 | 59.45M |
| March 15, 2024 | 52.88M |
| March 14, 2024 | 54.24M |
| March 13, 2024 | 53.08M |
| March 12, 2024 | 54.43M |
| March 11, 2024 | 52.30M |
| March 08, 2024 | 53.85M |
| March 07, 2024 | 54.24M |
| March 06, 2024 | 54.62M |
| March 05, 2024 | 59.26M |
| March 04, 2024 | 64.48M |
| March 01, 2024 | 66.99M |
| February 29, 2024 | 63.51M |
| February 28, 2024 | 57.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.102M
Minimum
Dec 21 2022
149.47M
Maximum
Nov 12 2021
45.52M
Average
38.98M
Median
Jul 26 2022
Enterprise Value Benchmarks
| Fortress Biotech Inc | -4.365M |
| Puma Biotechnology Inc | 225.85M |
| GT Biopharma Inc | -9.691M |
| FibroGen Inc | -10.07M |
| Outlook Therapeutics Inc | 198.86M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.143M |
| Revenue (Quarterly) | 15.26M |
| Total Expenses (Quarterly) | 17.36M |
| EPS Diluted (Quarterly) | -0.12 |
| Gross Profit Margin (Quarterly) | 60.58% |
| Profit Margin (Quarterly) | -14.05% |
| Earnings Yield | -9.80% |
| Operating Earnings Yield | 1.57% |
| Normalized Earnings Yield | -4.653 |